What is the expected CAGR of the global esomeprazole market during the forecast period (2022-2029)?
The global esomeprazole market is anticipated to reach a high CAGR during the forecast period, indicating a significant growth trajectory.
Which region holds the largest share of the global esomeprazole market?
North America currently dominates the global esomeprazole market, primarily due to factors like lifestyle changes, high prevalence of peptic ulcers, and robust healthcare infrastructure.
What are the major players operating in the global esomeprazole market?
The global esomeprazole market landscape is competitive, with key players including Daiichi Sankyo, AstraZeneca PLC, Zydus Cadila Pharmaceuticals Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc., Dr. Reddy's Laboratories Inc., Torrent Pharma Inc., Amneal Pharmaceuticals LLC, and Glenmark Pharmaceuticals.
Which segment is expected to dominate the esomeprazole market based on distribution channel?
Hospital pharmacies are expected to dominate the global esomeprazole market during the forecast period due to the increasing number of patients treated in hospitals and supportive reimbursement policies.